These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 18224294)

  • 1. PRL PTPs: mediators and markers of cancer progression.
    Bessette DC; Qiu D; Pallen CJ
    Cancer Metastasis Rev; 2008 Jun; 27(2):231-52. PubMed ID: 18224294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PRL-3 phosphatase and cancer metastasis.
    Al-Aidaroos AQ; Zeng Q
    J Cell Biochem; 2010 Dec; 111(5):1087-98. PubMed ID: 21053359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered expression of phosphatase of regenerating liver gene family in non-small cell lung cancer.
    Hwang JJ; Min SH; Sin KH; Heo YS; Kim KD; Yoo OJ; Lee SH
    Oncol Rep; 2012 Feb; 27(2):535-40. PubMed ID: 21993571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PRL-3: a metastasis-associated phosphatase in search of a function.
    Bessette DC; Wong PC; Pallen CJ
    Cells Tissues Organs; 2007; 185(1-3):232-6. PubMed ID: 17587829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A selective phosphatase of regenerating liver phosphatase inhibitor suppresses tumor cell anchorage-independent growth by a novel mechanism involving p130Cas cleavage.
    Daouti S; Li WH; Qian H; Huang KS; Holmgren J; Levin W; Reik L; McGady DL; Gillespie P; Perrotta A; Bian H; Reidhaar-Olson JF; Bliss SA; Olivier AR; Sergi JA; Fry D; Danho W; Ritland S; Fotouhi N; Heimbrook D; Niu H
    Cancer Res; 2008 Feb; 68(4):1162-9. PubMed ID: 18281492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein tyrosine phosphatases and breast cancer.
    Freiss G; Vignon F
    Crit Rev Oncol Hematol; 2004 Oct; 52(1):9-17. PubMed ID: 15363463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of PRL-3- and PRL-1-specific monoclonal antibodies as potential diagnostic markers for cancer metastases.
    Li J; Guo K; Koh VW; Tang JP; Gan BQ; Shi H; Li HX; Zeng Q
    Clin Cancer Res; 2005 Mar; 11(6):2195-204. PubMed ID: 15788667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver metastasis of colorectal cancer by protein-tyrosine phosphatase type 4A, 3 (PRL-3) is mediated through lymph node metastasis and elevated serum tumor markers such as CEA and CA19-9.
    Hatate K; Yamashita K; Hirai K; Kumamoto H; Sato T; Ozawa H; Nakamura T; Onozato W; Kokuba Y; Ihara A; Watanabe M
    Oncol Rep; 2008 Oct; 20(4):737-43. PubMed ID: 18813812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting phosphatases of regenerating liver (PRLs) in cancer.
    Wei M; Korotkov KV; Blackburn JS
    Pharmacol Ther; 2018 Oct; 190():128-138. PubMed ID: 29859177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of phosphatase of regenerating liver-3 in gastric cancer, its relationship with prognosis, and its role in gastric cancer cell proliferation].
    Cai SR; Chen CQ; Wang Z; He YL; Cui J; Wu WH; Wu H; Zhan WH
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(33):2326-30. PubMed ID: 19087692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein tyrosine phosphatases in cancer: friends and foes!
    Labbé DP; Hardy S; Tremblay ML
    Prog Mol Biol Transl Sci; 2012; 106():253-306. PubMed ID: 22340721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.
    Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH
    Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of integrin alpha1 as an interacting protein of protein tyrosine phosphatase PRL-3.
    Peng L; Jin G; Wang L; Guo J; Meng L; Shou C
    Biochem Biophys Res Commun; 2006 Mar; 342(1):179-83. PubMed ID: 16472776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MAPK-specific tyrosine phosphatases: new targets for drug discovery?
    Barr AJ; Knapp S
    Trends Pharmacol Sci; 2006 Oct; 27(10):525-30. PubMed ID: 16919785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of silencing phosphatase of regenerationg liver-3 expression by microRNA interference in the growth of gastric cancer.
    Cai SR; Wang Z; Chen CQ; Wu WH; He YL; Zhan WH; Zhang CH; Cui J; Wu H
    Chin Med J (Engl); 2008 Dec; 121(24):2534-8. PubMed ID: 19187591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PRL phosphatases as potential molecular targets in cancer.
    Stephens BJ; Han H; Gokhale V; Von Hoff DD
    Mol Cancer Ther; 2005 Nov; 4(11):1653-61. PubMed ID: 16275986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein tyrosine-phosphatase expression profiling in gastric cancer tissues.
    Wu CW; Kao HL; Li AF; Chi CW; Lin WC
    Cancer Lett; 2006 Oct; 242(1):95-103. PubMed ID: 16338072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An anticancer effect of curcumin mediated by down-regulating phosphatase of regenerating liver-3 expression on highly metastatic melanoma cells.
    Wang L; Shen Y; Song R; Sun Y; Xu J; Xu Q
    Mol Pharmacol; 2009 Dec; 76(6):1238-45. PubMed ID: 19779032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure of human PRL-3, the phosphatase associated with cancer metastasis.
    Kim KA; Song JS; Jee J; Sheen MR; Lee C; Lee TG; Ro S; Cho JM; Lee W; Yamazaki T; Jeon YH; Cheong C
    FEBS Lett; 2004 May; 565(1-3):181-7. PubMed ID: 15135076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Checks and balances: interplay of RTKs and PTPs in cancer progression.
    Sastry SK; Elferink LA
    Biochem Pharmacol; 2011 Sep; 82(5):435-40. PubMed ID: 21704606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.